Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth

Oncogene

Volumn 23, Issue 41, 2004, Pages 6986-6990

  Bajou, Khalid ^a   Maillard, Catherine ^a   Jost, Maud ^a   Lijnen, Roger H ^b   Gils, Ann ^c   Declerck, Paul ^c   Carmeliet, Peter ^d   Foidart, Jean Michel ^a   Noel, Agnès ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Cancer invasion; PAI 1; Protease inhibitor; Serine protease; Tumoral angiogenesis

Indexed keywords

COMPLEMENTARY DNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERINE PROTEINASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER INVASION; CONTROLLED STUDY; DOSE RESPONSE; GENE OVEREXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEINASE INHIBITION; TUMOR CELL; TUMOR GROWTH; VASCULARIZATION; ANIMAL; EXPERIMENTAL NEOPLASM; KERATINOCYTE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY;

ANIMALIA; MURINAE; MUS MUSCULUS;

ANIMALS; KERATINOCYTES; MICE; NEOPLASM INVASIVENESS; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 4644247804     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207859     Document Type: Article

References (26)

1. Almholt K, Nielsen BS, Frandsen TL, Brunner N, Dano K and Johnsen M. (2003). Oncogene, 22, 4389-4397.
2. Andreasen PA, Egelund R and Petersen HH. (2000). Cell Mol. Life Sci., 57, 25-40.
3. Bajou K, Masson V, Gerard RD, Schmitt PM, Albert V, Praus M, Lund LR, Frandsen TL, Brunner N, Dano K, Fusenig NE, Weidle U, Carmeliet G, Loskutoff D, Collen D, Carmeliet P, Foidart JM and Noel A. (2001). J. Cell Biol., 152, 777-784.
4. Bajou K, Noel A, Gerard RD, Masson V, Brunner N, Holst-Hansen C, Skobe M, Fusenig NE, Carmeliet P, Collen D and Foidart JM. (1998). Nat. Med., 4, 923-928.
5. Curino A, Mitola DJ, Aaronson H, McMahon GA, Raja K, Keegan AD, Lawrence DA and Bugge TH. (2002). Oncogene, 21, 8830-8842.
6. Czekay RP, Aertgeerts K, Curriden SA and Loskutoff DJ. (2003). J. Cell Biol., 160, 781-791.
7. Deng G, Curriden SA, Hu G, Czekay RP and Loskutoff DJ. (2001). J. Cell Physiol., 189, 23-33.
8. Deng G, Curriden SA, Wang S, Rosenberg S and Loskutoff DJ. (1996). J. Cell Biol., 134, 1563-1571.
9. Devy L, Blacher S, Grignet-Debrus C, Bajou K, Masson V, Gerard RD, Gils A, Carmeliet G, Carmeliet P, Declerck PJ, Noel A and Foidart JM. (2002). FASEB J., 16, 147-154.
10. Eitzman DT, Krauss JC, Shen T, Cui J and Ginsburg D. (1996). Blood, 87, 4718-4722.
11. Foekens JA, Peters HA, Look MP, Portengen H, Schmitt M, Kramer MD, Brunner N, Janicke F, Meijer-van Gelder ME, Henzen-Logmans SC, van Putten WL and Klijn JG. (2000). Cancer Res., 60, 636-643.
12. Gutierrez LS, Schulman A, Brito-Robinson T, Noria F, Ploplis VA and Castellino FJ. (2000). Cancer Res., 60, 5839-5847.
13. Isogai C, Laug WE, Shimada H, Declerck PJ, Stins MF, Durden DL, Erdreich-Epstein A and DeClerck YA. (2001). Cancer Res., 61, 5587-5594.
14. Kjoller L, Kanse SM, Kirkegaard T, Rodenburg KW, Ronne E, Goodman SL, Preissner KT, Ossowski L and Andreasen PA. (1997). Exp. Cell Res., 232, 420-429.
15. Lambert V, Munaut C, Carmeliet P, Gerard RD, Declerck PJ, Gils A, Claes C, Foidart JM, Noel A and Rakic JM. (2003). Invest Ophthalmol. Vis. Sci., 44, 2791-2797.
16. Lambert V, Munaut C, Noel A, Frankenne F, Bajou K, Gerard R, Carmeliet P, Defresne MP, Foidart JM and Rakic JM. (2001). FASEB J., 15, 1021-1027.
17. Lijnen HR, Van Hoef B, Umans K and Collen D. (2004). J. THromb. Haemost., 2, 16-22.
18. Liu G, Shuman MA and Cohen RL. (1995). Int. J. Cancer, 60, 501-506.
19. Masson V, Devy L, Grignet-Debrus C, Bernt S, Bajou K, Blacher S, Roland G, Chang Y, Fong T, Carmeliet P, Foidart JM and Noel A. (2002). Biol. Proc. Online, 4, 24-31.
20. McMahon GA, Petitclerc E, Stefansson S, Smith E, Wong MK, Westrick RJ, Ginsburg D, Brooks PC and Lawrence DA. (2001). J. Biol. Chem., 276, 33964-33968.
21. Montesano R, Pepper MS, Mohle-Steinlein U, Risau W, Wagner EF and Orci L. (1990). Cell, 62, 435-445.
22. Pepper MS and Montesano R. (1990). Cell Differ. Dev., 32, 319-327.
23. Rakic JM, Maillard C, Jost M, Bajou K, Masson V, Devy L, Lambert V, Foidart JM and Noel A. (2003). Cell Mol. Life Sci., 60, 463-473.
24. Soff GA, Sanderowitz J, Gately S, Verrusio E, Weiss I, Brem S and Kwaan HC. (1995). J. Clin. Invest., 96, 2593-2600.
25. Stefansson S, Petitclerc E, Wong MK, McMahon GA, Brooks PC and Lawrence DA. (2001). J. Biol. Chem., 276, 8135-8141.
26. Stephens RW, Brunner N, Janicke F and Schmitt M. (1998). Breast Cancer Res. Treat., 52, 99-111.